238 related articles for article (PubMed ID: 19491893)
1. UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer.
Unoki M; Kelly JD; Neal DE; Ponder BA; Nakamura Y; Hamamoto R
Br J Cancer; 2009 Jul; 101(1):98-105. PubMed ID: 19491893
[TBL] [Abstract][Full Text] [Related]
2. UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer.
Yang GL; Zhang LH; Bo JJ; Chen HG; Cao M; Liu DM; Huang YR
Med Oncol; 2012 Jun; 29(2):842-7. PubMed ID: 21611839
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression.
Ying L; Lin J; Qiu F; Cao M; Chen H; Liu Z; Huang Y
FEBS J; 2015 Jan; 282(1):174-82. PubMed ID: 25323766
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma.
Pi JT; Lin Y; Quan Q; Chen LL; Jiang LZ; Chi W; Chen HY
Med Oncol; 2013 Dec; 30(4):613. PubMed ID: 24005809
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer.
Saidi S; Popov Z; Janevska V; Panov S
Int Braz J Urol; 2017; 43(2):224-229. PubMed ID: 28128913
[TBL] [Abstract][Full Text] [Related]
6. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1.
Zhang Y; Huang Z; Zhu Z; Zheng X; Liu J; Han Z; Ma X; Zhang Y
PLoS One; 2014; 9(10):e104252. PubMed ID: 25272010
[TBL] [Abstract][Full Text] [Related]
7. UHRF1 is a novel diagnostic marker of lung cancer.
Unoki M; Daigo Y; Koinuma J; Tsuchiya E; Hamamoto R; Nakamura Y
Br J Cancer; 2010 Jul; 103(2):217-22. PubMed ID: 20517312
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients.
Geng Y; Gao Y; Ju H; Yan F
Cancer Sci; 2013 Feb; 104(2):194-9. PubMed ID: 23107467
[TBL] [Abstract][Full Text] [Related]
9. Analysis of UHRF1 expression in human ovarian cancer tissues and its regulation in cancer cell growth.
Yan F; Wang X; Shao L; Ge M; Hu X
Tumour Biol; 2015 Nov; 36(11):8887-93. PubMed ID: 26070868
[TBL] [Abstract][Full Text] [Related]
10. Expression of Bmi-1 is a prognostic marker in bladder cancer.
Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
[TBL] [Abstract][Full Text] [Related]
11. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the UHRF1 expression in serum and tissue for gastric cancer detection.
Ge M; Gui Z; Wang X; Yan F
Biomarkers; 2015; 20(3):183-8. PubMed ID: 26161699
[TBL] [Abstract][Full Text] [Related]
13. The correlation between miR-146a C/G polymorphism and UHRF1 gene expression level in gastric tumor.
Soleimani A; Ghanadi K; Noormohammadi Z; Irani S
J Dig Dis; 2016 Mar; 17(3):169-74. PubMed ID: 26896831
[TBL] [Abstract][Full Text] [Related]
14. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.
Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL
Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation.
Zhang ZY; Cai JJ; Hong J; Li KK; Ping Z; Wang Y; Ng HK; Yao Y; Mao Y
Med Oncol; 2016 Sep; 33(9):99. PubMed ID: 27449774
[TBL] [Abstract][Full Text] [Related]
16. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
[TBL] [Abstract][Full Text] [Related]
17. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
18. Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients.
Che X; Yang D; Zong H; Wang J; Li X; Chen F; Chen X; Song X
Urol Oncol; 2012; 30(4):450-6. PubMed ID: 21795072
[TBL] [Abstract][Full Text] [Related]
19. UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma.
Nakamura K; Baba Y; Kosumi K; Harada K; Shigaki H; Miyake K; Kiyozumi Y; Ohuchi M; Kurashige J; Ishimoto T; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Nakao M; Baba H
Oncotarget; 2016 Sep; 7(36):57821-57831. PubMed ID: 27507047
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of UHRF1 promotes the progression of melanoma by inducing cell proliferation.
Wei C; Lu N; Wang L; Zhang Y; Feng Z; Yang Y; Qi F; Gu J
Oncol Rep; 2018 Jun; 39(6):2553-2562. PubMed ID: 29620240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
